by admin | Apr 21, 2025 | News & Opinions
by Kadeja Johnson – RegMedNet – 4basebio PLC has received a Good Manufacturing Practice certification from the UK Medicine and Healthcare Regulatory Agency (London), authorizing the company to supply GMP-grade synthetic DNA as both a starting material and...
by admin | Apr 18, 2025 | News & Opinions
By Smriti Mallapaty – Nature – Induced pluripotent stem cells are being tested to treat blindness, paralysis, Parkinson’s disease and more. Approvals might be around the corner. Japan is brimming with signs of an approaching medical revolution. Shiny white robots are...
by admin | Apr 17, 2025 | News & Opinions
By Ned Pagliarulo – PharmaVoice – A commission urged the U.S. government to prioritize biotechnology funding and policies to stay ahead of China in fields it argued are vital to national security. The U.S. risks losing a once-decisive edge over China in...
by admin | Apr 15, 2025 | News & Opinions
This is where the world’s top innovators, thought leaders, entrepreneurs, and investors come together to build a better world with synthetic biology. Join us in San Jose as we explore how synbio is transforming industries from healthcare, agriculture,...
by admin | Apr 14, 2025 | News & Opinions
By Katherine Eban – Vanity Fair – If you’ve ever used eye drops that didn’t blind you, thank Dr. Timothy J. Pohlhaus. As of yesterday, he’s gone. And if you’ve ever been injected with a sterile drug that helped heal you instead of killing you, you have...
by admin | Apr 13, 2025 | News & Opinions
By Cristy Lytal – Keck School of Medicine of USC – The same genes could hold the key to regenerating cells in the ear and eye, according to a new mouse study from the USC Stem Cell laboratory of Ksenia Gnedeva, published in the Proceedings of the National...
